MannKind to Present at the Piper Jaffray 20th Annual Health Care Conference

Wednesday, November 26, 2008 General News J E 4
VALENCIA, Calif., Nov. 25 MannKind Corporation(Nasdaq: MNKD), focused on discovering, developing and commercializingtreatments for diabetes and cancer, announced today that it will present atthe Piper Jaffray 20th Annual Health Care Conference on Tuesday, December 2,2008 at 2:30 PM (EST) at the New York Palace Hotel in New York City.

Interested parties can access a link to the live web cast of thepresentation in the Investor Relations section of the Company's website at A replay of the presentation will be availablefor 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, developmentand commercialization of therapeutic products for patients with diseases suchas diabetes and cancer. Its pipeline includes AFRESA, which has completedPhase 3 clinical trials, and MKC253, which is currently in phase 1 clinicaltrials. Both of these investigational products are being evaluated for theirsafety and efficacy in the treatment of diabetes. MannKind maintains a websiteat to which MannKind regularly posts copies ofits press release as well as additional information about MannKind.Interested persons can subscribe on the MannKind website to email alerts thatare sent automatically when MannKind issues press releases, files its reportswith the SEC or posts certain other information to the website.

SOURCE MannKind Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
As Consumers Put a Leash on Spending, Experts Caut...
Mother of Five Wins $5,000 in Minnesota Quit-Smoki...